FDA Grants Approval for RSV Vaccine to Protect Newborns Through Expectant Mothers
In a groundbreaking development, U.S. regulators have granted approval for the first ever vaccine against respiratory syncytial virus (RSV) for pregnant women. This vaccine, called Abrysvo and manufactured by Pfizer, aims to protect infants from severe cases of RSV during their first six months of life. RSV is a particularly dangerous respiratory infection that often …